GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (OCSE:GUBRA) » Definitions » Gross-Profit-to-Asset %

Gubra AS (OCSE:GUBRA) Gross-Profit-to-Asset % : 19.17% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Gubra AS Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Gubra AS's annualized Gross Profit for the quarter that ended in Dec. 2023 was kr119.7 Mil. Gubra AS's average Total Assets over the quarter that ended in Dec. 2023 was kr624.3 Mil. Therefore, Gubra AS's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 19.17%.


Gubra AS Gross-Profit-to-Asset % Historical Data

The historical data trend for Gubra AS's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gubra AS Gross-Profit-to-Asset % Chart

Gubra AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
- 50.57 66.71 34.60 25.88

Gubra AS Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial - 29.18 40.83 24.86 19.17

Competitive Comparison of Gubra AS's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Gubra AS's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gubra AS's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gubra AS's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Gubra AS's Gross-Profit-to-Asset % falls into.



Gubra AS Gross-Profit-to-Asset % Calculation

Gubra AS's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=114.936/( (262.902+625.28)/ 2 )
=114.936/444.091
=25.88 %

Gubra AS's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=119.684/( (623.417+625.28)/ 2 )
=119.684/624.3485
=19.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Gubra AS Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Gubra AS's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Gubra AS (OCSE:GUBRA) Business Description

Traded in Other Exchanges
Address
Hørsholm Kongevej 11B, Hørsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases.

Gubra AS (OCSE:GUBRA) Headlines

No Headlines